Genetic variants ofTgfb1act as context-dependent modifiers of mouse skin tumor susceptibility
- 23 May 2006
- journal article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 103 (21) , 8125-8130
- https://doi.org/10.1073/pnas.0602581103
Abstract
The human TGFB1 gene is polymorphic, and genetic variants are associated with altered cancer risk. However, human genetic association studies have had variable outcomes because TGFbeta1 action is context-dependent. We used the murine skin model of chemical carcinogenesis in genetic linkage analysis of three independent Mus musculus NIH/Ola x (Mus spretus x M. musculus NIH/Ola)F1 backcrosses, to identify a skin tumor susceptibility locus, Skts14, on proximal chromosome 7. Tgfb1 maps at the peak of linkage. The mouse Tgfb1 gene is polymorphic, resulting in cis-regulated differential allelic mRNA expression between M. spretus and M. musculus in F1 mouse skin. This phenomenon is reflected in differential phospho-SMAD2 levels, downstream of TGFbeta signaling, between these two mouse species. In normal F1 mouse skin, the Tgfb1SPR allele is expressed at higher levels than the Tgfb1NIH allele, and this differential is accentuated by phorbol 12-myristate 13-acetate treatment. In benign F1 papillomas, this imbalance is reversed, possibly by selection against expression of a hyperactive Tgfb1SPR allele in TGFbeta growth-responsive tumors. We demonstrate that skin tumor susceptibility is altered by Tgfb1 gene dosage, but that manifestation of Tgfb1-linked skin tumor susceptibility in M. musculus NIH/Ola x (M. spretus x M. musculus NIH/Ola)F1 backcross mice depends on interactions with another unlinked tumor modifying locus, Skts15, that overlaps Tgfbm3 on chromosome 12. These findings illustrate the power of complex genetic interactions in determining disease outcome and have major implications to the assessment of disease risk in individuals harboring variant TGFB1 alleles.Keywords
This publication has 48 references indexed in Scilit:
- The great MYC escape in tumorigenesisCancer Cell, 2005
- Genetic Polymorphisms of the Transforming Growth Factor-β1 Gene and Breast Cancer Risk: A Possible Dual Role at Different Cancer StagesCancer Epidemiology, Biomarkers & Prevention, 2005
- Whole genome scanning identifies genotypes associated with recurrence and metastasis in prostate tumorsHuman Molecular Genetics, 2004
- Identification of Stk6/STK15 as a candidate low-penetrance tumor-susceptibility gene in mouse and humanNature Genetics, 2003
- TGF-β antagonists: Why suppress a tumor suppressor?Journal of Clinical Investigation, 2002
- TGF- β signaling in cancer – a double-edged swordTrends in Cell Biology, 2001
- Polymorphisms of the Transforming Growth Factor-β1 Gene in Relation to Myocardial Infarction and Blood PressureHypertension, 1996
- Distinct genetic loci control development of benign and malignant skin tumours in miceNature Genetics, 1995
- Anti-transforming growth factor (TGF)-beta antibodies inhibit breast cancer cell tumorigenicity and increase mouse spleen natural killer cell activity. Implications for a possible role of tumor cell/host TGF-beta interactions in human breast cancer progression.Journal of Clinical Investigation, 1993
- Genetic changes in skin tumor progression: Correlation between presence of a mutant ras gene and loss of heterozygosity on mouse chromosome 7Cell, 1990